Richard Young

Richard A. Young founded Dewpoint Therapeutics, Inc. in 2020, Syros Pharmaceuticals, Inc. in 2011, where he worked as Independent Director from 2011 to 2024, and CAMP4 Therapeutics Corp.
in 2016, where he is working as Independent Director from 2016.
Dr. Young also currently works at Precede Biosciences, Inc., as Director from 2023, Paratus Sciences Corp., as Director from 2021, Massachusetts Institute of Technology, as Professor-Biology from 1984, and Whitehead Institute for Biomedical Research, as Member from 1984.
Dr. Young also formerly worked at Enzon Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, Omega Therapeutics, Inc., as Independent Director from 2017 to 2024, and Eastern Alloys, Inc., as Senior Vice President-Steel Mill Product Sales.
Dr. Young received his undergraduate degree from Indiana University and doctorate degree in 1975 from Yale University.